DK2986722T3 - Manipulerede phenylalaninammoniak-lyasepolypeptider - Google Patents

Manipulerede phenylalaninammoniak-lyasepolypeptider Download PDF

Info

Publication number
DK2986722T3
DK2986722T3 DK14784792.5T DK14784792T DK2986722T3 DK 2986722 T3 DK2986722 T3 DK 2986722T3 DK 14784792 T DK14784792 T DK 14784792T DK 2986722 T3 DK2986722 T3 DK 2986722T3
Authority
DK
Denmark
Prior art keywords
phenylalaninammonic
lyasepolypeptides
manipulated
phenylalaninammonic lyasepolypeptides
manipulated phenylalaninammonic
Prior art date
Application number
DK14784792.5T
Other languages
English (en)
Inventor
Gjalt W Huisman
Nicholas J Agard
Benjamin Mijts
Jonathan Vroom
Xiyun Zhang
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Application granted granted Critical
Publication of DK2986722T3 publication Critical patent/DK2986722T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/01—Ammonia-lyases (4.3.1)
    • C12Y403/01005—Phenylalanine ammonia-lyase (4.3.1.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/01—Ammonia-lyases (4.3.1)
    • C12Y403/01024—Phenylalanine ammonia-lyase (4.3.1.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
DK14784792.5T 2013-04-18 2014-04-17 Manipulerede phenylalaninammoniak-lyasepolypeptider DK2986722T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361813586P 2013-04-18 2013-04-18
US201361897932P 2013-10-31 2013-10-31
PCT/US2014/034500 WO2014172541A2 (en) 2013-04-18 2014-04-17 Engineered phenylalanine ammonia lyase polypeptides

Publications (1)

Publication Number Publication Date
DK2986722T3 true DK2986722T3 (da) 2019-05-13

Family

ID=51729192

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19163814.7T DK3521423T3 (da) 2013-04-18 2014-04-17 Manipulerede phenylalaninammoniaklyase-polypeptider
DK14784792.5T DK2986722T3 (da) 2013-04-18 2014-04-17 Manipulerede phenylalaninammoniak-lyasepolypeptider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19163814.7T DK3521423T3 (da) 2013-04-18 2014-04-17 Manipulerede phenylalaninammoniaklyase-polypeptider

Country Status (27)

Country Link
US (17) US9611468B2 (da)
EP (3) EP3971288A1 (da)
JP (5) JP6637410B2 (da)
KR (1) KR102218930B1 (da)
CN (2) CN105324483B (da)
AU (2) AU2014253900C1 (da)
CA (1) CA2909719C (da)
CY (1) CY1121891T1 (da)
DK (2) DK3521423T3 (da)
EA (1) EA034034B1 (da)
ES (2) ES2890955T3 (da)
HR (1) HRP20190928T1 (da)
HU (2) HUE055899T2 (da)
IL (1) IL242067B (da)
LT (1) LT2986722T (da)
MX (1) MX366196B (da)
MY (1) MY193198A (da)
NZ (1) NZ713396A (da)
PE (1) PE20151775A1 (da)
PH (1) PH12015502412A1 (da)
PL (1) PL2986722T3 (da)
PT (1) PT2986722T (da)
RS (1) RS58802B1 (da)
SG (1) SG11201508598YA (da)
SI (1) SI2986722T1 (da)
SM (1) SMT201900315T1 (da)
WO (1) WO2014172541A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ713396A (en) 2013-04-18 2020-06-26 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
WO2015161019A1 (en) 2014-04-16 2015-10-22 Codexis, Inc. Engineered tyrosine ammonia lyase
ES2881384T3 (es) 2015-05-13 2021-11-29 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
CN106636048A (zh) * 2016-12-14 2017-05-10 江南大学 一株酶活提高的苯丙氨酸脱氨酶突变体
CN106755160B (zh) * 2017-01-17 2019-08-02 湖州颐辉生物科技有限公司 一种组氨酸解氨酶及其用途
MX2019009615A (es) 2017-02-13 2019-10-14 Codexis Inc Polipeptidos dise?ados de fenilalanina amonio liasa.
CN110914288B (zh) * 2017-05-27 2023-05-05 宁波酶赛生物工程有限公司 工程化醛缩酶多肽及其应用
CN111655841A (zh) 2017-06-21 2020-09-11 同生运营公司 用于治疗紊乱的细菌
US10900055B2 (en) * 2018-06-12 2021-01-26 Codexis, Inc. Engineered tyrosine ammonia lyase
JP2021531749A (ja) * 2018-07-12 2021-11-25 コデクシス， インコーポレイテッド 操作されたフェニルアラニンアンモニアリアーゼポリペプチド
AU2019373208A1 (en) * 2018-10-29 2021-05-13 Codexis, Inc. Engineered DNA polymerase variants
CA3122524A1 (en) 2018-12-14 2020-06-18 Codexis, Inc. Engineered tyrosine ammonia lyase
WO2021168060A1 (en) * 2020-02-19 2021-08-26 Trustees Of Tufts College Methods for engineering amino acid ammonia lyase enzymes and enzymes thereby obtained
BR112022018571A2 (pt) * 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
CN116847860A (zh) * 2020-12-31 2023-10-03 同生运营公司 经工程化以减轻高苯丙氨酸血症的微生物
CA3220735A1 (en) * 2021-05-21 2022-11-24 Codexis, Inc. Engineered methionine gamma lyase variants
CN114015636B (zh) * 2021-12-08 2023-09-29 天地壹号饮料股份有限公司 重组醋酸菌及其制备方法和应用
CN114457151B (zh) * 2022-01-27 2024-06-11 宁夏医科大学总医院 一种用于检测苯丙氨酸羟化酶基因突变的检测试剂盒及其检测方法
CN117417925A (zh) * 2022-07-18 2024-01-19 浙江泽科塔生物医药有限公司 Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法
CN115518691B (zh) * 2022-10-14 2023-11-21 天津大学 一种具有类漆酶活性的人工酶及制备方法和应用
CN115873837A (zh) * 2022-11-18 2023-03-31 安徽盈科生物科技有限公司 高表达的新型的苯丙氨酸解氨酶
CN116478975B (zh) * 2023-06-16 2023-09-01 苏州优信合生技术有限公司 高活性苯丙氨酸解氨酶突变体及其表达菌株
TW202519654A (zh) * 2023-09-19 2025-05-16 日商積水化學工業股份有限公司 解氨酶及其用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603344A (en) 1898-05-03 Trough for well-curbs
US753653A (en) 1903-09-14 1904-03-01 American Car & Foundry Co Hopper-bottom car.
DK75593D0 (da) * 1993-06-25 1993-06-25 Novo Nordisk As
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
FI964808A0 (fi) 1994-06-03 1996-12-02 Novo Nordisk Biotech Inc Puhdistetut Myceliophthora lakkaasit ja niitä koodaavat nukleiinihapot
CN101659926A (zh) 1994-06-30 2010-03-03 诺沃奇梅兹有限公司 非毒性、非产毒性、非致病性镰孢属表达系统及所用启动子和终止子
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
KR100570935B1 (ko) 1997-01-17 2006-04-13 맥시겐, 인크. 반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6537746B2 (en) 1997-12-08 2003-03-25 Maxygen, Inc. Method for creating polynucleotide and polypeptide sequences
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
ES2341217T3 (es) 1999-01-19 2010-06-17 Maxygen, Inc. Recombinacion de acidos nucleicos mediada por oligonucleotidos.
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
EP1272967A2 (en) 2000-03-30 2003-01-08 Maxygen, Inc. In silico cross-over site selection
US6967097B2 (en) * 2000-07-24 2005-11-22 Pcbu Services, Inc. Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
JP5319865B2 (ja) 2002-03-01 2013-10-16 コデクシス メイフラワー ホールディングス， エルエルシー 機能的生体分子を同定する方法、システム、およびソフトウェア
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP1488335A4 (en) 2002-03-09 2006-11-15 Maxygen Inc OPTIMIZING CROSSOVER POINTS FOR THE ADJUSTED EVOLUTION
US8003356B2 (en) 2004-04-20 2011-08-23 E. I. Du Pont De Nemours And Company Methods for the preparation of para-hydroxycinnamic acid and cinnamic acid at alkaline pH
WO2006034373A2 (en) 2004-09-17 2006-03-30 Biomarin Pharmaceutical Inc. Variants and chemically-modified variants of phenylalanine ammonia-lyase
EP2886658A1 (en) 2005-03-10 2015-06-24 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7534595B2 (en) * 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US20090011400A1 (en) * 2006-12-01 2009-01-08 The Salk Institute for Biological Studies and The Regents of the University of California Substrate switched ammonia lyases and mutases
US7560263B2 (en) 2007-08-17 2009-07-14 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
DK3023494T3 (da) 2008-06-13 2019-02-25 Codexis Inc Fremgangsmåde til syntese af polynukleotidvarianter
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
ES2690542T3 (es) 2010-02-04 2018-11-21 Biomarin Pharmaceutical Inc. Método para purificar variantes de fenilalanina amoníaco-liasa procariotas
US20130340119A1 (en) 2010-11-05 2013-12-19 Basf Plant Science Company Gmbh Method for Increasing Yield and Fine Chemical Production in Plants
US9150884B2 (en) 2011-03-08 2015-10-06 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Microbial conversion of glucose to styrene and its derivatives
WO2012178126A1 (en) 2011-06-23 2012-12-27 Phytogene, Inc. Enzymatic system for monomer synthesis
NZ713396A (en) 2013-04-18 2020-06-26 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides

Also Published As

Publication number Publication date
US20180016568A1 (en) 2018-01-18
US10494623B2 (en) 2019-12-03
LT2986722T (lt) 2019-09-10
US10487319B2 (en) 2019-11-26
CN105324483A (zh) 2016-02-10
US20180037880A1 (en) 2018-02-08
ES2890955T3 (es) 2022-01-25
JP2018166524A (ja) 2018-11-01
DK3521423T3 (da) 2021-09-06
NZ713396A (en) 2020-06-26
AU2014253900B2 (en) 2019-09-19
US10941391B2 (en) 2021-03-09
JP6637410B2 (ja) 2020-01-29
US20200199566A1 (en) 2020-06-25
JP2022183356A (ja) 2022-12-08
PH12015502412B1 (en) 2016-02-22
AU2014253900A1 (en) 2015-11-12
PL2986722T3 (pl) 2019-10-31
US20210222146A1 (en) 2021-07-22
PE20151775A1 (es) 2015-12-02
AU2014253900C1 (en) 2020-04-02
US20200032233A1 (en) 2020-01-30
US20200032234A1 (en) 2020-01-30
US10640759B2 (en) 2020-05-05
US20190055535A1 (en) 2019-02-21
US20200032235A1 (en) 2020-01-30
US10144924B2 (en) 2018-12-04
US9611468B2 (en) 2017-04-04
US20200032236A1 (en) 2020-01-30
SMT201900315T1 (it) 2019-07-11
CN109486803B (zh) 2022-10-25
PH12015502412A1 (en) 2016-02-22
US20140314843A1 (en) 2014-10-23
US20200399627A1 (en) 2020-12-24
US10160963B2 (en) 2018-12-25
ES2729048T3 (es) 2019-10-30
SI2986722T1 (sl) 2019-07-31
SG11201508598YA (en) 2015-11-27
KR102218930B1 (ko) 2021-02-23
US10717974B2 (en) 2020-07-21
US20170191050A1 (en) 2017-07-06
RS58802B1 (sr) 2019-07-31
MX2015014662A (es) 2016-03-03
US11136571B2 (en) 2021-10-05
US20200231959A1 (en) 2020-07-23
EP3971288A1 (en) 2022-03-23
EP2986722A4 (en) 2017-02-22
AU2019272057A1 (en) 2019-12-19
US20200040325A1 (en) 2020-02-06
WO2014172541A2 (en) 2014-10-23
CN105324483B (zh) 2018-11-30
BR112015026160A2 (pt) 2017-10-10
EA034034B1 (ru) 2019-12-20
US11913045B2 (en) 2024-02-27
PT2986722T (pt) 2019-06-21
EP3521423A1 (en) 2019-08-07
KR20150143816A (ko) 2015-12-23
JP7129715B2 (ja) 2022-09-02
HRP20190928T1 (hr) 2019-07-26
HUE055899T2 (hu) 2022-01-28
US11401515B2 (en) 2022-08-02
US20190241882A1 (en) 2019-08-08
AU2019272057B2 (en) 2021-05-27
US20190055536A1 (en) 2019-02-21
US11130947B2 (en) 2021-09-28
JP2020185016A (ja) 2020-11-19
EP2986722A2 (en) 2016-02-24
EP2986722B1 (en) 2019-04-03
MY193198A (en) 2022-09-26
EP3521423B1 (en) 2021-07-21
US10870843B2 (en) 2020-12-22
US10294468B2 (en) 2019-05-21
IL242067B (en) 2018-03-29
JP2016516428A (ja) 2016-06-09
US10975367B2 (en) 2021-04-13
MX366196B (es) 2019-07-01
WO2014172541A3 (en) 2015-02-19
EA201591995A1 (ru) 2016-04-29
CN109486803A (zh) 2019-03-19
US20190040377A1 (en) 2019-02-07
US10358639B2 (en) 2019-07-23
CA2909719C (en) 2022-09-27
JP2020185017A (ja) 2020-11-19
CY1121891T1 (el) 2020-10-14
HUE043549T2 (hu) 2019-08-28
CA2909719A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
NL301171I2 (nl) Tigolaner
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
DK3077047T3 (da) Aramcholsalte
DK3052081T3 (da) Pastil
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T3 (da) Bindestrimler
EP2943489A4 (en) DEUTERATED MOMELOTINIB
DK2946640T3 (da) Langmuir-probe
DE102013106534B8 (de) Chromatographiepipettenspitze
EP2991647A4 (en) DEUTERED AMLEXANOX
EP2970310A4 (en) 5-BROMO-indirubins
EP2853297A4 (en) kendama
DK3071227T3 (da) Fiskevaccine
DE112014001252A5 (de) Aufbissschiene
DK3086679T3 (da) Sportssko
DK2981168T3 (da) Laminitiskile
FI10343U1 (fi) Mittateippi
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
ES1100380Y (es) Trompo